Development of new chitosan-cellulose multicore microparticles for controlled drug delivery

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 45, Issue 1, 1998, Pages 49-56

  Remunan Lopez C ^a   Lorenzo Lamosa, M L ^a   Vila Jato, J L ^a   Alonso, M J ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Anti inflammatory drugs; Cellulose acetate butyrate; Chitosan; Controlled release; Ethyl cellulose; Microencapsulation; Oral administration; Protein delivery

Indexed keywords

BOVINE SERUM ALBUMIN FLUORESCEIN ISOTHIOCYANATE LABELED; CELLABURATE; CHITOSAN; DICLOFENAC; ETHYL CELLULOSE; FLUORESCEIN ISOTHIOCYANATE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; MICROENCAPSULATION; ORAL DRUG ADMINISTRATION;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELLULOSE; CHITIN; CHITOSAN; DELAYED-ACTION PREPARATIONS; DICLOFENAC; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; FLUORESCEIN-5-ISOTHIOCYANATE; PARTICLE SIZE; SERUM ALBUMIN, BOVINE;

EID: 0345647087     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(97)00122-7     Document Type: Article

References (25)

1. J. Knapczyk, L. Krówczynski, J. Krzek, M. Brzeski, E. Nurnberg, D. Schenk, H. Struszcyk, Requirements of chitosan for pharmaceutical and biomedical applications, in: G. Skåk-Bræk, T. Anthonsen, P. Sandford (Eds.), Chitin and Chitosan: Sources, Chemistry, Biochemistry, Physical Properties and Applications, Elsevier, London, 1989, pp. 657-663.
2. S. Hirano, H. Seino, I. Akiyama, I. Nonaka, Chitosan: a biocompatible material for oral and intravenous administrations, in: C.G. Gebelein, R.L. Dunn (Eds.), Progress in Biomedical Polymers, Plenum, New York, 1990, pp. 283-289.
3. Hou W.M., Miyazaki S., Takada M., Komai T. Sustained release of indomethacin from chitosan granules. Chem. Pharm. Bull. 33:1985;3986-3992.
4. Sawayanagi Y., Nambu N., Nagai T. Enhancement of dissolution properties of griseofulvin from ground mixtures with chitin or chitosan. Chem. Pharm. Bull. 30:1982;4464-4467.
5. Lehr C.M., Bouwstra J.A., Schacht E.H., Junginger H.E. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm. 78:1992;43-48.
6. Illum L., Farraj N.F., Davis S.S. Chitosan as a novel nasal delivery system for peptide drugs. Pharm. Res. 11:1994;1186-1189.
7. Borchard G., Lueßen H.L., de Boer G.A., Coos Verhoef J., Lehr C.M., Junginger H.E. The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro. J. Control. Release. 39:1996;131-138.
8. Tozaki H., Fujita T., Yamamoto A., Muranishi S., Sugiyama T., Terabe A., Matsumoto T., Suzuki T. Chitosan capsules for colon specific drug delivery: improvement of insulin absorption from the rat colon. Proc. Int. Symp. Control. Release Bioact. Mater. 23:1996;551-552.
9. Bodmeier R., Oh K.H., Pramar Y. Preparation and evaluation of drug-containing chitosan beads. Drug Dev. Ind. Pharm. 15:1989;1475-1494.
10. Calvo P., Remuñán-López C., Vila-Jato J.L., Alonso M.J. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J. Appl. Polym. Sci. 63:1997;125-132.
11. Remuñán-López C., Bodmeier R. Mechanical and water vapor transmission properties of polysaccharide films. Drug Dev. Ind. Pharm. 22:1996;1201-1209.
12. Berthold A., Cremer K., Kreuter J. Influence of crosslinking on the acid stability and physicochemical properties of chitosan microspheres. S.T.P. Pharma. 6:1996;358-364.
13. Remuñan-López C., Alonso M.J., Calleja T., Vila-Jato J.L., Bodmeier R. Development of new chitosan-gelatin microcapsules produced by a complex coacervation process. Proc. Int. Symp. Control. Release Bioact. Mater. 22:1995;430-431.
14. Genta I., Pavanetto F., Conti B., Giunchedi P., Conte U. Improvement of dexamethasone dissolution rate from spray-dried chitosan microspheres. S.T.P. Pharma. 5:1995;202-207.
15. Akbuga J., Durmaz G. Preparation and evaluation of cross-linked chitosan microspheres containing furosemide. Int. J. Pharm. 111:1994;217-222.
16. J. Karlsen, Excipient properties of chitosan, Manufacturing Chemist, June (1991) 18-19.
17. Hillyard I.W., Doczi J., Kiernan P.B. Antacid and antiulcer properties of the polysaccharide chitosan. Proc. Soc. Exp. Biol. Med. 115:1964;1108-1112.
18. Alex R., Bodmeier R. Encapsulation of water-soluble drugs by a modified solvent evaporation method. I. Effect of process and formulation variables on drug encapsulation. J. Microencapsulation. 7:1990;347-355.
19. Alonso M.J., Cohen S., Park T.G., Gupta R.J., Siber G.R., Langer R. Determinants of release rate of tetanus vaccine from polyester microspheres. Pharm. Res. 10:1993;945-953.
20. Herrmann J., Bodmeier R. Somatostatin containing biodegradable microspheres prepared by a modified solvent evaporation method based on W/O/W-multiple emulsions. Int. J. Pharm. 126:1995;129-138.
21. Kienzle-Sterzer C.A., Rodríguez-Sánchez D., Rha C. Mechanical Properties of chitosan films: effect of solvent acid. Makromol. Chem. 183:1982;1353-1359.
22. Hosokawa J., Nishiyama M., Yoshihara K., Kubo T., Terabe A. Reaction between chitosan and cellulose on biodegradable composite film formation. Ind. Eng. Chem. Res. 30:1991;788-792.
23. Chen R.H., Lin J.H., Yang M.H. Relationships between the chain flexibilities of chitosan molecules and the physical properties of their casted films. Carbohydr. Polym. 24:1994;41-46.
24. Nigalaye A.G., Adusumilli P., Bolton S. Investigation of prolonged drug release from matrix formulations of chitosan. Drug Dev. Ind. Pharm. 16:1990;449-467.
25. 2 full factorial design. Drug Dev. Ind. Pharm. 17:1991;1931-1945.